| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 检测服务收入(元) | 32,504,937.59 | 66,559,007.01 | 32,208,921.13 | 84,935,851.14 | 44,743,728.77 |
| 检测试剂收入(元) | 483,334,684.62 | 876,853,512.43 | 447,818,918.25 | 859,875,765.97 | 383,573,600.20 |
| 药物临床研究服务(元) | 56,988,281.06 | 160,896,610.26 | 59,987,816.73 | 88,706,635.50 | 25,411,066.30 |
| 营业成本(元) | |||||
| 检测服务收入(元) | 16,688,132.64 | 51,174,778.39 | 15,633,632.48 | 54,261,873.94 | 25,528,426.88 |
| 检测试剂收入(元) | 44,845,878.80 | 84,541,941.51 | 40,792,979.15 | 80,639,333.62 | 36,290,099.50 |
| 药物临床研究服务(元) | 26,707,033.52 | 30,250,040.49 | 22,223,276.45 | 25,945,760.37 | 9,922,750.37 |
| 毛利(元) | |||||
| 检测服务收入(元) | 15,816,804.95 | 15,384,228.62 | 16,575,288.65 | 30,673,977.20 | 19,215,301.89 |
| 检测试剂收入(元) | 438,488,805.82 | 792,311,570.92 | 407,025,939.10 | 779,236,432.35 | 347,283,500.70 |
| 药物临床研究服务(元) | 30,281,247.54 | 130,646,569.77 | 37,764,540.28 | 62,760,875.13 | 15,488,315.93 |
| 毛利率(%) | |||||
| 检测服务收入(%) | 48.66 | 23.11 | 51.46 | 36.11 | 42.95 |
| 检测试剂收入(%) | 90.72 | 90.36 | 90.89 | 90.62 | 90.54 |
| 药物临床研究服务(%) | 53.14 | 81.20 | 62.95 | 70.75 | 60.95 |
| 收入构成(%) | |||||
| 检测服务收入(%) | 5.67 | 6.03 | 5.96 | 8.22 | 9.86 |
| 检测试剂收入(%) | 84.38 | 79.40 | 82.93 | 83.20 | 84.54 |
| 药物临床研究服务(%) | 9.95 | 14.57 | 11.11 | 8.58 | 5.60 |
| 毛利构成(%) | |||||
| 检测服务收入(%) | 3.26 | 1.64 | 3.59 | 3.51 | 5.03 |
| 检测试剂收入(%) | 90.49 | 84.44 | 88.22 | 89.29 | 90.91 |
| 药物临床研究服务(%) | 6.25 | 13.92 | 8.19 | 7.19 | 4.05 |